57361EGP
- Active ingredient
- trastuzumab deruxtecan
- Strength
- 100mg
- Form
- vial
- Manufacturer
- EGYPTIAN PHARMACEUTICAL TRADING COMPANY
- Route
- injection
Uses
Used for selected HER2-positive cancers including breast and other HER2-expressing tumors.
Do not use if
No specific labeled contraindications, but avoid use in severe hypersensitivity.
Side effects
Nausea, fatigue, neutropenia, anemia, and interstitial lung disease may occur.
Warnings
Monitor closely for interstitial lung disease, cardiac dysfunction, and embryo-fetal toxicity.
How it works
HER2-directed antibody-drug conjugate delivering a topoisomerase I inhibitor to tumor cells.
Storage
Store refrigerated at 2–8°C and protect from light.